Mechanotransduction — fibroblast shape and YAP/TAZ
This page describes a pathway reported in the literature. It is not a claim about any product and does not recommend any procedure.
Mechanisms
How does the mechanical signal a fibroblast receives connect to dermal collagen production?
This pathway runs in the opposite direction to the usual reading. Rather than cells building matrix, the description is that matrix transmits force to cells, that force sustains the spread shape of the cell, and that shape in turn governs expression of matrix-related genes. In aged human dermis, fibroblasts have been reported to adopt a contracted morphology as the matrix deteriorates, with the YAP/TAZ and TGF-beta pathways impaired together. Injectable materials have been discussed as a possible intervention in that environment, but the connection is currently at the level of a narrative review.
Reported sequence
| Step | What the literature reports | Basis |
|---|---|---|
| Matrix transmits force to the cell | The dermal extracellular matrix transmits force to fibroblasts, and the cell holds a spread state under that force. The review describes force transmission as impaired when the matrix becomes fragmented and disorganised. | PMID 42505292 |
| Loss of transmission is described alongside reduced synthesis | Reduced cell spreading and force generation are associated with increased matrix metalloproteinase expression and reduced collagen synthesis, with c-Jun/AP-1 activation and attenuated TGF-beta signalling identified as part of that route. | PMID 42505292 |
| Cell size moves the transcriptional coactivators | In human dermal fibroblasts, cell spreading and size were reported to regulate CCN2 expression in a YAP/TAZ-dependent manner. The same study reported that restoring cell size rapidly reversed the decline in CCN2. | PMID 35480397 |
| The axis is reported as lowered in aged human skin | Using three-dimensional multiphoton imaging and single-cell transcriptomics, aged dermis showed matrix deterioration, reduced fibroblast attachment and a contracted morphology, with TGF-beta/Smad and YAP/TAZ — two pathways governing matrix homeostasis — impaired together. | PMID 42586406 |
| Restoring shape is reported to restore homeostasis | Culture models reproducing the contracted morphology showed the same impairments, and restoring fibroblast spreading was reported to normalise the disrupted collagen homeostasis. | PMID 42586406 |
| The attempt to connect injectable materials to this framework | The review describes a filler's material properties as potentially constituting a mechanical exposure, while stating alongside it that bulk rheological measurements do not define force transmission at the cellular scale. It identifies human in vivo studies of crosslinked hyaluronic acid as the most direct evidence, and describes evidence for CaHA and other biostimulatory materials as complementary but more heterogeneous. | PMID 42505292 |
Evidence that reads the other way
The review cited here is a narrative review, and its authors state that the causal role of YAP/TAZ mechanosignalling in aging human dermis remains unresolved. The same paper discloses that two of its authors hold an advisory relationship with the manufacturer of a product discussed as a case example, and states that this may bias the selection and interpretation of the literature it cites. This page carries that disclosure across unchanged. The evidence linking cell size to YAP/TAZ comes from work on aging itself; that injecting a material reverses this axis is a proposed connection rather than a measured result in humans.
Materials where this is cited
Evidence
| PMID | Study type | Summary |
|---|---|---|
| 42505292 | review | Narrative review of matrix aging, dermal fibroblast mechanotransduction, and how injectable fillers may influence the dermal mechanical environment. Author conflicts of interest disclosed in the paper — Gels, 2026 |
| 35480397 | in vitro | Reports that cell size regulates CCN2 expression in human dermal fibroblasts in a YAP/TAZ-dependent manner, with the decline reversed on restoring size — JID Innov, 2022 |
| 42586406 | in vivo | Reports contracted fibroblast morphology and impaired TGF-beta/Smad and YAP/TAZ signalling in aged human skin using three-dimensional imaging and single-cell transcriptomics — J Invest Dermatol, 2026 |
The arrow points the other way
The usual reading goes like this: fibroblasts make collagen, they make less of it with age, and so the matrix thins. The literature cited here also draws the arrow in reverse. When the matrix deteriorates, less force reaches the cell; with less force the cell contracts and flattens; and a contracted cell switches on fewer matrix genes. One paper calls this an “outside-in” adaptation.
The direction matters because it moves the point of intervention. Stimulating a cell and changing the environment a cell sits in are not the same operation.
The observation that it can be reversed
The most striking item in this set is the restoration experiment. Two studies each report that when fibroblast spreading or size was restored, what had declined came back. One records that CCN2 expression reversed rapidly; the other records that collagen homeostasis was normalised.
There is a condition to hold on to. That restoration was obtained by manipulating cell shape directly under culture conditions. It is not an observation that placing a material in tissue produces the same event.
The evidence thins at the point where materials enter
Discussion exists on whether injectable materials can intervene in this mechanical environment, but the paper that organises it is a narrative review, and it states its own limits more than once: that the causal role is unresolved, that the weight of evidence differs by material, and that its authors have a disclosed conflict of interest.
All three are carried across here for a reason. This pathway is frequently cited in product literature, and when it is, those three rarely travel with it.
Not reading rheology as evidence for this pathway
The review states one sentence plainly: bulk rheological measurements do not define force transmission at the cellular scale. The storage modulus in a product document is a rheometer value, and a large value there does not translate into a large force at the cell. It is the same caution recorded on this site’s crosslinked hyaluronic acid page.
Limitations & open questions
No study measuring this pathway in humans before and after placement of a material was found in the searches behind this page. The mechanobiology evidence cited here comes from work on aging itself, and the connection to fillers is made by a narrative review, which states that the weight of evidence differs between materials. Bulk rheological values do not define force transmission at the cellular scale, so a storage modulus figure in product literature cannot be read as evidence for this pathway. YAP/TAZ is studied across many tissues outside skin, and findings from other tissues require separate confirmation before being carried to the dermis.